Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,988 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

NCT05246345

Conditions: CLL, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
Locations: CHU d'Amiens Amiens, France

CHU de Besançon Besançon, France

Hopital AVICENNE Bobigny, France

CHU clermont-ferrand Clermont-Ferrand, France

View all 14 locations

View Trial Details

Recruiting

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

NCT05127148

Conditions: Acute Lymphoblastic Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Instituto Privado de Hematologia y Hemoterapia Paraná, Entre Ríos Province, Argentina

FUNDALEU CABA, Argentina

View Trial Details

Recruiting

Genotype-guided Treatment in Newly Diagnosed PTCL

NCT05675813

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Ruijin hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.

NCT05833763

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peter MacCallum Cancer Centre Parkville, Victoria, Australia

Sir Charles Gairdener Nedlands, Western Australia, Australia

View Trial Details

Recruiting

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

NCT06180174

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Danish Elder Lymphoma Patient Hematopoietic Investigation

NCT05245487

Conditions: Chemotherapeutic Toxicity, Chemotherapy-Related Leukemia, Chemotherapy-induced Neutropenia, +8 more
Locations: Dept. of Hematology, Rigshospitalet Copenhagen, Denmark

View Trial Details

Recruiting

Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients

NCT06176729

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL

NCT05694312

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: Ematologia Osp Careggi Florence, Italy

Ematologia Osp Maggiore della Carità Novara, Italy

Ematologia Osp Molinette Torino, Italy

View Trial Details

Recruiting

A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT06136351

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study

NCT06136364

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Shanghai Ruijin Hospital Shanghai, China

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions